ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,500.98
0.25%
Dow Jones
38,927.84
0.24%
US Dollar vs MXN
18.3884
-0.25%
Brent Oil
85.14
0.53%
Bitcoin
65,168.90
0.32%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cingulate Inc (CINGW)

  7. Cingulate Inc (CINGW) Noticias

CINGW Cingulate Inc

0.0103
0.00 (0.00%)
Última actualización: 08:35:46
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cingulate Inc CINGW NASDAQ Warrant Capital Accionario
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.0103 08:35:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0103 0.0103 0.0103 0.0103
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/6/202416:00EDGAR2Form PRE 14A - Other preliminary proxy statements
18/6/202407:00EDGAR2Form 8-K - Current report
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202416:00EDGAR2Form 8-K - Current report
07/6/202417:00EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202416:54EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202408:20EDGAR2Form 8-K - Current report
23/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202416:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202408:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
17/5/202416:01EDGAR2Form S-1 - General form for registration of securities under..
13/5/202407:00EDGAR2Form 8-K - Current report
08/5/202406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202406:10EDGAR2Form 8-K - Current report
08/5/202406:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30/4/202404:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202416:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202407:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202415:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/3/202405:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13/2/202405:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
06/2/202415:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
02/2/202408:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202407:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202405:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
01/12/202308:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
13/11/202315:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
17/10/202313:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
21/9/202312:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
13/9/202315:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11/9/202308:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11/9/202305:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
08/9/202315:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05/9/202307:00GLOBECingulate Announces Presentation of Full Trial Results from..
14/8/202315:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11/7/202307:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29/6/202307:00GLOBECingulate Successfully Manufactures Clinical Supply –..

Su Consulta Reciente

NASDAQ
CINGW
Cingulate
TSXV
CTEC
Central Timmins Explorat...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados